Around two-thirds of our total reports come from general practitioners and, whilst they provide invaluable data, we wish to receive many more reports from hospitals, where patients with the most serious ADRs are likely to be managed. * we need more reports from specialists (eg, oncologists, haematologists) using 'niche' products. They tend to be the predominant prescribers of many novel agents, such as products derived from biotechnological sources, and could provide us with a wealth of valuable information.
Please support the 'yellow card' system.
